Related Experiment Video
Updated: Nov 26, 2025
05:45
Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma
Published on: January 19, 2024
2.5K
Shared decision making in high-grade glioma patients-a systematic review
Helle Sorensen von Essen1,2, Karin Piil3,4, Karina Dahl Steffensen5,6,7
1Department of Neurosurgery, Odense University Hospital, Odense C, Denmark.
Neuro-Oncology Practice
|December 11, 2020
Summary
High-grade glioma patients often prefer shared decision making (SDM), which can improve emotional well-being. However, current evidence is limited, necessitating further research for better patient decision support.
Area of Science:
- Neuro-oncology
- Patient-centered care
- Decision science
Background:
- Shared decision making (SDM) is valuable for treatment decisions.
- High-grade glioma (HGG) patients face numerous treatment choices.
- HGG patients often experience cognitive decline, impacting decision capacity.
Purpose of the Study:
- To review current knowledge on SDM from the HGG patient perspective.
- To understand HGG patient preferences for SDM in treatment planning.
Main Methods:
- Systematic literature searches across major databases (MEDLINE, CINAHL, PsycINFO, EMBASE).
- Inclusion criteria screening and methodological quality assessment.
- Narrative synthesis of descriptive data from four included studies (178 HGG patients).
Main Results:
- Most HGG patients appreciated SDM, with information and involvement enhancing emotional well-being.
- Patient decision aids showed potential to increase knowledge and reduce uncertainty.
- SDM influenced treatment decision-making processes for HGG patients.
Conclusions:
- Many HGG patients favor SDM, which may improve emotional well-being.
- The current evidence base for SDM in HGG is weak.
- Further research is needed to develop robust decision support for HGG patients.
